Epidemiology and risk factors of the cardiometabolic syndrome in the Middle East

References

• Poirier P, Giles TD, Bray GA et al. Obesity and cardiovascular disease: pathophysiology, evaluation and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity and Metabolism. Circulation113(6), 898–918 (2006).
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA285(19), 2486–2497 (2001).
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet366(9491), 1059–1062 (2005).
   PubMed Web of Science ®Google Scholar
• Despres JP, Arsenault BJ, Cote M, Cartier A, Lemieux I. Abdominal obesity: the cholesterol of the 21st Century? Can. J. Cardiol.24(Suppl. D), 7D–12D (2008).
   PubMedGoogle Scholar
• Prentice AM. The emerging epidemic of obesity in developing countries. Int. J. Epidemiol.35(1), 93–99 (2006).
   PubMed Web of Science ®Google Scholar
• Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet360(9343), 1347–1360 (2002).
   PubMed Web of Science ®Google Scholar
• Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann. Intern. Med.138(1), 24–32 (2003).
   PubMed Web of Science ®Google Scholar
• James WPT, Jackson-Leach R, Mhurchu C et al. Overweight and obesity (high body mass index). In: Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Ezzati M, Lopez AD, Rodgers A, Murray CJ (Eds). WHO, Geneva, Switzerland (2004).
   Google Scholar
• Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med.162(16), 1867–1872 (2002).
   PubMed Web of Science ®Google Scholar
• Kenchaiah S, Evans JC, Levy D et al. Obesity and the risk of heart failure. N. Engl. J. Med.347(5), 305–313 (2002).
   PubMed Web of Science ®Google Scholar
• Motlagh B, O’Donnell M, Yusuf S. Prevalence of cardiovascular risk factors in the Middle East: a systematic review. Eur. J. Cardiovasc. Prev. Rehabil.16(3), 268–280 (2009).
   PubMedGoogle Scholar
• Esteghamati A, Meysamie A, Khalilzadeh O et al. Third National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity and dyslipidemia. BMC Public Health9, 167 (2009).
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Khalilzadeh O, Mohammad K et al. Secular trends of obesity in Iran between 1999 and 2007: National Surveys of Risk Factors of Non-Communicable Diseases. Metab. Syndr. Relat. Disord.8(3), 209–213 (2010).
   PubMed Web of Science ®Google Scholar
• al-Isa AN. Changes in body mass index (BMI) and prevalence of obesity among Kuwaitis 1980–1994. Int. J. Obes. Relat. Metab. Disord.21(12), 1093–1099 (1997).
   PubMedGoogle Scholar
• Al-Lawati JA, Jousilahti PJ. Prevalence and 10-year secular trend of obesity in Oman. Saudi. Med. J.25(3), 346–351 (2004).
   PubMedGoogle Scholar
• Sheffer R, Calderon-Margalit R. Trends in overweight, obesity and blood pressure among Israeli working adults – implications for public health. Eur. J. Public Health18(2), 121–125 (2008).
   PubMedGoogle Scholar
• Maes HH, Neale MC, Eaves LJ. Genetic and environmental factors in relative bodyweight and human adiposity. Behav. Genet.27(4), 325–351 (1997).
   PubMed Web of Science ®Google Scholar
• Hinney A, Vogel CI, Hebebrand J. From monogenic to polygenic obesity: recent advances. Eur. Child Adolesc. Psychiatry19(3), 297–310 (2010).
   PubMed Web of Science ®Google Scholar
• Haslam DW, James WP. Obesity. Lancet366(9492), 1197–1209 (2005).
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Khalilzadeh O, Anvari M, Rashidi A, Mokhtari M, Nakhjavani M. Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity. Metab. Syndr. Relat. Disord.7(5), 447–452 (2009).
   PubMed Web of Science ®Google Scholar
• Galal O. Nutrition-related health patterns in the Middle East. Asia Pac. J. Clin. Nutr.12(3), 337–343 (2003).
   PubMed Web of Science ®Google Scholar
• King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections. Diabetes Care21(9), 1414–1431 (1998).
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care27(5), 1047–1053 (2004).
   PubMed Web of Science ®Google Scholar
• Chan JC, Malik V, Jia W et al. Diabetes in Asia: epidemiology, risk factors and pathophysiology. JAMA301(20), 2129–2140 (2009).
   PubMed Web of Science ®Google Scholar
• Abdella N, Al Arouj M, Al Nakhi A, Al Assoussi A, Moussa M. Non-insulin-dependent diabetes in Kuwait: prevalence rates and associated risk factors. Diabetes Res. Clin. Pract.42(3), 187–196 (1998).
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Khalilzadeh O, Anvari M et al. The economic costs of diabetes: a population-based study in Tehran, Iran. Diabetologia52(8), 1520–1527 (2009).
   PubMed Web of Science ®Google Scholar
• Jeon CY, Lokken RP, Hu FB, van Dam RM. Physical activity of moderate intensity and risk of Type 2 diabetes: a systematic review. Diabetes Care30(3), 744–752 (2007).
   PubMed Web of Science ®Google Scholar
• Ahmed Khoja T, Al-Shoumer K, Sulimani R et al. Diabetes: the hidden pandemic and its impact on the Middle East and Northen Africa (MENA). Dubai (2010).
   Google Scholar
• International Diabetes Federation. IDF Diabetes Atlas (4th Edition). International Diabetes Federation, Brussels, Belgium (2009).
   Google Scholar
• Esteghamati A, Ashraf H, Khalilzadeh O et al. Trends of diabetes according to body mass index levels in Iran: results of the national Surveys of Risk Factors of Non-Communicable Diseases (1999–2007). Diabet. Med.27(11), 1233–1240 (2010).
   PubMedGoogle Scholar
• Esteghamati A, Gouya MM, Abbasi M et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care31(1), 96–98 (2008).
   PubMed Web of Science ®Google Scholar
• El-kebbi IM, Engelgau MM. The burden of diabetes and its complications in the Middle East and Eastern Mediterranean region. In: The Epidemiology of Diabetes Mellitus. Ekoé JM, Rewers M, Williams R, Zimmet P (Eds). John Wiley & Sons, Ltd, Chichester, UK, 121–131 (2008).
   Google Scholar
• Mansour AA, Wanoose HL, Hani I, Abed-Alzahrea A, Wanoose HL. Diabetes screening in Basrah, Iraq: a population-based cross-sectional study. Diabetes Res. Clin. Pract.79(1), 147–150 (2008).
   PubMedGoogle Scholar
• Shera AS, Rafique G, Khawaja IA, Baqai S, King H. Pakistan National Diabetes Survey: prevalence of glucose intolerance and associated factors in Baluchistan province. Diabetes Res. Clin. Pract.44(1), 49–58 (1999).
   PubMedGoogle Scholar
• Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys. Ther.88, 1254–1264 (2008).
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature414, 782–787 (2001).
   PubMed Web of Science ®Google Scholar
• Bamba V, Rader DJ. Obesity and atherogenic dyslipidemia. Gastroenterology132, 2181–2190 (2007).
   PubMed Web of Science ®Google Scholar
• Lopez AD. Global Burden of Disease and Risk Factors. Mathers D, Ezzati M, Jamison DT, Murray C (Eds). World Bank, Washington DC, USA (2006).
   Google Scholar
• WHO. Chapter 4: Quantifying selected major risks to health. In: The World Health Report 2002 – Reducing Risks, Promoting Healthy Life. WHO, Geneva, Switzerland, 47–97 (2002).
   Google Scholar
• Dickinson S, Colagiuri S, Faramus E, Petocz P, Brand-Miller JC. Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities. J. Nutr.132(9), 2574–2579 (2002).
   PubMed Web of Science ®Google Scholar
• Wu Y, Li H, Loos RJ et al. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8 and HHEX/IDE genes are associated with Type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes Care57(10), 2834–2842 (2008).
   Google Scholar
• Yokoi N, Kanamori M, Horikawa Y et al. Association studies of variants in the genes involved in pancreatic β-cell function in Type 2 diabetes in Japanese subjects. Diabetes Care55(8), 2379–2386 (2006).
   Google Scholar
• Esteghamati A, Khalilzadeh O, Anvari M, Seyed Ahadi M, Abbasi M, RashidiA. Metabolic syndrome and insulin resistance significantly correlate with body mass index. Arch. Med. Res.39, 803–808 (2008).
   PubMedGoogle Scholar
• Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res. Clin. Pract.82(1), 104–107 (2008).
   PubMedGoogle Scholar
• Esteghamati A, Zandieh A, Khalilzadeh O, Morteza A, Meysamie A, Nakhjavani M, Gouya MM. Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis. Endocrine38, 206–213 (2010).
   PubMedGoogle Scholar
• Esteghamati A, Khalilzadeh O, Rashidi A, Kamgar M, Meysamie A, Abbasi M. Physical activity in Iran: Results of the Third National Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). J. Phys. Act. Health8(1), 27–35 (2011).
   PubMedGoogle Scholar
• Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care29(9), 2114–2116 (2006).
   PubMed Web of Science ®Google Scholar
• Malik VS, Schulze MB, Hu FB. Intake of sugarsweetened beverages and weight gain: a systematic review. Am. J. Clin. Nutr.84, 274–288 (2006).
   PubMed Web of Science ®Google Scholar
• Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int. J. Epidemiol.30, 540–546 (2001).
   PubMed Web of Science ®Google Scholar
• Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of Type 2 diabetes: a systematic review and meta-analysis. JAMA298, 2654–2664 (2007).
   PubMed Web of Science ®Google Scholar
• Meysamie A, Ghaletaki R, Haghazali M et al. Pattern of tobacco use among the Iranian adult population: results of the national Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Tob. Control19, 125–128 (2010).
   PubMed Web of Science ®Google Scholar
• Smith DG. Epidemiology of dyslipidemia and economic burden on the healthcare system. Am. J. Manag. Care13(Suppl. 3), S68–S71 (2007).
   PubMed Web of Science ®Google Scholar
• Jackson RT, al-Mousa Z, al-Raqua M, Prakash P, Muhanna A. Prevalence of coronary risk factors in healthy adult Kuwaitis. Int. J. Food Sci. Nutr.52, 301–311 (2001).
   PubMedGoogle Scholar
• Olusi SO, Al-Awadi AM, Abraham M. Baseline population survey data on the prevalence of risk factors for coronary artery disease among Kuwaitis aged 15 years and older. Ann. Saudi. Med.23, 162–166 (2003).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). State-specific cholesterol screening trends: United States, 1991–1999. MMWR Morb. Mortal. Wkly. Rep.49, 750 –755 (2000).
   PubMedGoogle Scholar
• Al-Nuaim AR, Al-Rubeaan K, Al-Mazrou Y, Al-Attas O, Al-Daghari N. Prevalence of hypercholesterolemia in Saudi Arabia, epidemiological study. Int. J. Cardiol.54, 41–49 (1996).
   PubMedGoogle Scholar
• Mahley RW, Palaoğlu KE, Atak Z et al. Turkish Heart Study: lipids, lipoproteins and apolipoproteins. J. Lipid Res.36, 839–859 (1995).
   PubMed Web of Science ®Google Scholar
• Al-Riyami AA, Afifi MM. Prevalence and correlates of obesity and central obesity among Omani adults. Saudi. Med. J.24, 641–646 (2003).
   PubMedGoogle Scholar
• Lloyd-Jones D, Adams R, Carnethon M et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics–2009 Update A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation119, e21–e181 (2009).
   PubMed Web of Science ®Google Scholar
• Firmann M, Mayor V, Vidal PM et al. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc. Disord.8, 6 (2008).
   PubMed Web of Science ®Google Scholar
• Al-Nozha MM, Arafah MR, Al-Maatouq MA et al. Hyperlipidemia in Saudi Arabia. Saudi. Med. J.29, 282–287 (2008).
   PubMed Web of Science ®Google Scholar
• Erem C, Hacihasanoglu A, Deger O et al. Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study. Endocrine33, 9–20 (2008).
   PubMedGoogle Scholar
• Sibai AM, Obeid OA, Batal M, Adra N, Dit El Khoury DT, Hwalla N. Prevalence and correlates of metabolic syndrome in an adult Lebanese population. Prev. Control3, 83–90 (2008).
   Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA287(3), 356–359 (2002).
   PubMed Web of Science ®Google Scholar
• Miccoli R, Bianchi C, Odoguardi L et al. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr. Metab. Cardiovasc. Dis.15, 250–254 (2005).
   PubMed Web of Science ®Google Scholar
• Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes41(6), 715–722 (1992).
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med.23(5), 469–480 (2006).
   PubMed Web of Science ®Google Scholar
• Yoon YS, Lee ES, Park C, Lee S, Oh SW. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int. J. Obes.31(3), 528–534 (2007).
   PubMed Web of Science ®Google Scholar
• Tong PC, Kong AP, So WY et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program’s Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with Type 2 diabetes. Diabetes Care30(5), 1206–1211 (2007).
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Abbasi M, Rashidi A et al. Optimal waist circumference cutoffs for the diagnosis of metabolic syndrome in Iranian adults: results of the third national survey of risk factors of non-communicable diseases (SuRFNCD-2007). Diabet. Med.26(7), 745–746 (2009).
   PubMedGoogle Scholar
• Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis191(1), 182–190 (2007).
   PubMed Web of Science ®Google Scholar
• Al Rashdan I, Al Nesef Y. Prevalence of overweight, obesity and metabolic syndrome among adult Kuwaitis: results from community-based national survey. Angiology61(1), 42–48 (2010).
   PubMed Web of Science ®Google Scholar
• Mansour AA, Al-Hassan AA, Al-Jazairi MI. Cut-off values for waist circumference in rural Iraqi adults for the diagnosis of metabolic syndrome. Rural Remote Health7(4), 765 (2007).
   PubMedGoogle Scholar
• Maggi S, Noale M, Gallina P et al. Metabolic syndrome, diabetes and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J. Gerontol. A. Biol. Sci. Med. Sci.61(5), 505–510 (2006).
   PubMed Web of Science ®Google Scholar
• Patel A, Huang KC, Janus ED et al. Is a single definition of the metabolic syndrome appropriate? A comparative study of the USA and Asia. Atherosclerosis184(1), 225–232 (2006).
   PubMedGoogle Scholar
• Kozan O, Oguz A, Abaci A et al. Prevalence of the metabolic syndrome among Turkish adults. Eur. J. Clin. Nutr.61(4), 548–553 (2007).
   PubMed Web of Science ®Google Scholar
• Malik M, Razig SA. The prevalence of the metabolic syndrome among the multiethnic population of the United Arab Emirates: a report of a national survey. Metab. Syndr. Relat. Disord.6(3), 177–186 (2008).
   PubMedGoogle Scholar
• Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study. Metab. Syndr. Relat. Disord.7(3), 221–229 (2009).
   PubMed Web of Science ®Google Scholar
• Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Sabico SL, Chrousos GP. Decreasing prevalence of the full metabolic syndrome but a persistently high prevalence of dyslipidemia among adult Arabs. PLoS One5(8), e12159 (2010).
   Google Scholar
• Esteghamati A, Khalilzadeh O, Rashidi A et al. Association between physical activity and metabolic syndrome in Iranian adults: national surveillance of risk factors of noncommunicable diseases (SuRFNCD-2007). Metabolism58(9), 1347–1355 (2009).
   PubMed Web of Science ®Google Scholar
• Mabry RM, Reeves MM, Eakin EG, Owen N. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diabet. Med.27(5), 593–597 (2010).
   PubMed Web of Science ®Google Scholar
• Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health6, 92 (2006).
   PubMed Web of Science ®Google Scholar
• Lorenzo C, Serrano-Rios M, Martinez-Larrad MT et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care29(3), 685–691 (2006).
   PubMedGoogle Scholar
• Feng Y, Hong X, Li Z et al. Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population. Obesity (Silver Spring)14(11), 2089–2098 (2006).
   PubMed Web of Science ®Google Scholar
• Al-Nozha M, Al-Khadra A, Arafah MR et al. Metabolic syndrome in Saudi Arabia. Saudi. Med. J.26(12), 1918–1925 (2005).
   PubMed Web of Science ®Google Scholar
• Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res. Clin. Pract.67(3), 251–257 (2005).
   PubMed Web of Science ®Google Scholar
• McKeigue PM, Ferrie JE, Pierpoint T, Marmot MG. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation87(1), 152–161 (1993).
   PubMed Web of Science ®Google Scholar
• Whincup PH, Gilg JA, Papacosta O et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ324(7338), 635 (2002).
   PubMed Web of Science ®Google Scholar
• Al-Nozha MM, Al-Mazrou YY, Al-Maatouq MA et al. Obesity in Saudi Arabia. Saudi. Med. J.26(5), 824–829 (2005).
   PubMed Web of Science ®Google Scholar
• Al-Tawil NG, Abdulla MM, Abdul Ameer AJ. Prevalence of and factors associated with overweight and obesity among a group of Iraqi women. East Mediterr. Health J.13(2), 420–429 (2007).
   PubMedGoogle Scholar
• Berrios X, Koponen T, Huiguang T, Khaltaev N, Puska P, Nissinen A. Distribution and prevalence of major risk factors of noncommunicable diseases in selected countries: the WHO Inter-Health Programme. Bull. World Health Organ.75(2), 99–108 (1997).
   PubMed Web of Science ®Google Scholar
• Iseri A, Arslan N. Obesity in adults in Turkey: age and regional effects. Eur. J. Public Health19(1), 91–94 (2009).
   PubMed Web of Science ®Google Scholar
• Keinan-Boker L, Noyman N, Chinich A, Green MS, Nitzan-Kaluski D. Overweight and obesity prevalence in Israel: findings of the first national health and nutrition survey (MABAT). Isr. Med. Assoc. J.7(4), 219–223 (2005).
   PubMed Web of Science ®Google Scholar
• Malik M, Bakir A, Saab BA, King H. Glucose intolerance and associated factors in the multi-ethnic population of the United Arab Emirates: results of a national survey. Diabetes Res. Clin. Pract.69, 188–195 (2005).
   PubMed Web of Science ®Google Scholar
• Maziak W, Rastam S, Mzayek F, Ward KD, Eissenberg T, Keil U. Cardiovascular health among adults in Syria: a model from developing countries. Ann. Epidemiol.17(9), 713–720 (2007).
   PubMed Web of Science ®Google Scholar
• Moosa K, Abdul Wahab AW, Gharib N, Al Sairafi M, Al Raees G, Al Amer M. National Nutrition Survey for Adult Bahrainis Aged 19 Years and Above. Kingdom of Bahrain Ministry of Health, Bahrain (2002).
   Google Scholar
• Sibai AM, Hwalla N, Adra N, Rahal B. Prevalence and covariates of obesity in Lebanon: findings from the first epidemiological study. Obes. Res.11(11), 1353–1361 (2003).
   PubMedGoogle Scholar
• Stene LC, Giacaman R, Abdul-Rahim H, Husseini A, Norum KR, Holmboe-Ottesen G. Obesity and associated factors in a Palestinian West Bank village population. Eur. J. Clin. Nutr.55(9), 805–811 (2001).
   PubMedGoogle Scholar
• Zindah M, Belbeisi A, Walke H, Mokdad AH. Obesity and diabetes in Jordan: findings from the behavioral risk factor surveillance system, 2004. Prev. Chronic. Dis.5(1), A17 (2008).
   PubMedGoogle Scholar
• Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: an urban–rural comparison. Diabetes Care24(2), 275–279 (2001).
   PubMedGoogle Scholar
• Albache N, Al Ali R, Rastam S, Fouad FM, Mzayek F, Maziak W. Epidemiology of Type 2 diabetes mellitus in Aleppo, Syria. J. Diabetes2(2), 85–91 (2010).
   PubMedGoogle Scholar
• Al-Moosa S, Allin S, Jemiai N, Al-Lawati J, Mossialos E. Diabetes and urbanization in the Omani population: an analysis of National Survey data. Popul. Health Metr.4, 5 (2006).
   PubMedGoogle Scholar
• Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY et al. Diabetes mellitus in Saudi Arabia. Saudi. Med. J.25, 1603–1610 (2004).
   PubMed Web of Science ®Google Scholar
• Bener A, Zirie M, Janahi I, Al-Hamaq A, Musallam M, Wareham N. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res. Clin. Pract.84, 99–106 (2009).
   PubMed Web of Science ®Google Scholar
• Chodick G, Heymann AD, Shalev V, Kookia E. The epidemiology of diabetes in a large Israeli HMO. Eur. J. Epidemiol.18, 1143–1146 (2003).
   PubMed Web of Science ®Google Scholar
• Herman WH, Aubert RE, Ali MA, Sous ES, Badran A. Diabetes mellitus in Egypt: risk factors, prevalence and future burden. East Mediter. Health J.3, 144–148 (1997).
   Google Scholar
• Hirbli KI, Jambeine MA, Slim HB, Barakat WM, Habis RJ, Francis ZM. Prevalence of diabetes in greater Beirut. Diabetes Care28, 1262 (2005).
   PubMedGoogle Scholar
• Loizou T, Pouloukas S, Tountas C, Thanopoulou A, Karamanos V. An epidemiologic study on the prevalence of diabetes, glucose intolerance and metabolic syndrome in the adult population of the Republic of Cyprus. Diabetes Care29, 1714–1715 (2006).
   PubMedGoogle Scholar
• Satman I, Yilmaz T, Sengül A et al. Population-based study of diabetes and risk characteristics in Turkey. Diabetes Care25(9), 1551–1556 (2002).
   PubMed Web of Science ®Google Scholar
• Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care26(6), 1781–1785 (2003).
   PubMed Web of Science ®Google Scholar
• Erem C, Hacihasanoglu A, Deger O, Kocak M, Topbas M. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study. Endocrine34, 36–51 (2008).
   PubMed Web of Science ®Google Scholar
• Khader YS, Batieha A, El-Khateeb M, Omari M, Ajlouni K. Prevalence of dyslipidemia and its associated factors among Jordanian adults. J. Clin. Lipidol.4, 53–58 (2010).
   PubMedGoogle Scholar
• Mula-Abed WA, Chilmeran SK. Prevalence of dyslipidemia in the Iraqi adult population. Saudi. Med. J.28, 1868–1874 (2007).
   PubMedGoogle Scholar